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INTRODUCTION
Seroma, which is one of the most common complications in 
prosthetic breast reconstruction, increases the incidence of oth-
er morbidities, such as surgical site infection, and the length of 
hospital stay. Of particular note, in patients with breast cancer, 
seroma development can lead to delays in the administration of 
adjuvant therapy. Several hypotheses have been proposed re-
garding seroma development. Seromas may be the consequence 
of surgical disruption of both the lymphatics and capillaries [1], 
injuries of the surrounding lymph vessels due to heat dispersion 
[2], and the consequence of inflammatory exudates [3]. In our 
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opinion, all three of these hypotheses may be valid to some ex-
tent [4]. The causes of seroma development in breast recon-
struction are thought to include the presence of a large irregular 
dead space, lymphatic disruption that occurs after total mastec-
tomy, insertion of a foreign body, chest wall movement, and 
persistent inflammation in response to the tissue damage that 
occurs during the surgical process [1,4-6].
Monopolar electrosurgical devices have been frequently used 
for nearly 50 years. Fulguration, precise vaporization, and coap-
tation of large vessels are facilitated by using an electrosurgical 
device instead of a conventional scalpel; thus, bleeding is con-
trolled relatively easily, which is advantageous for securing visi-
bility and reducing operating time [7]. However, the use of a 
monopolar electrosurgical device is associated with the risk of 
seroma formation after surgery because it causes thermal dam-
age to the surrounding tissue. Studies have reported that using a 
monopolar electrosurgical device resulted in an increase in the 
seroma formation rate and drainage volume compared to a con-
ventional scalpel [8]. Therefore, various advantages and disad-
vantages are associated with the use of monopolar electrosurgi-
cal devices in breast surgery.
Recently, ultrasonic dissection devices have been introduced 
as an alternative. These devices use ultrasonic waves to dissect 
the tissue, making it possible to perform a more sophisticated 
dissection with a narrower circumference of collateral thermal 
damage to the surrounding tissue compared to the damage 
caused by monopolar electrosurgical devices [9]. Furthermore, 
bleeding control and dissection can be performed simultane-
ously, and there is a lack of surgical smoke and reduced charring; 
consequently, a clearer visual field can be secured. Studies have 
already reported that using an ultrasonic dissection device in-
stead of an electrosurgical device for radical mastectomy was as-
sociated with a significant decrease in the incidence of seroma 
development [10-12].
To date, no study has investigated the surgical outcomes ob-
tained by using an ultrasonic dissection device in comparison 
with those obtained by using a monopolar electrosurgical ener-
gy device during prosthetic breast reconstruction. Therefore, 
this study compared the effects of using an ultrasonic dissection 
device or a monopolar electrosurgical device during prosthesis-




The study was conducted at the plastic surgery department of 
our hospital, and the study protocol was approved by the Insti-
tutional Review Board of Gangnam Severance Hospital. Pa-
tients who underwent total mastectomy at the breast surgery 
unit and immediate reconstruction with a prosthesis from 
March 2017 to September 2018 were enrolled. We retrospec-
tively reviewed the patients’ medical records. Patients who un-
derwent bilateral breast reconstruction, those who underwent 
additional procedures such as contralateral breast manipulations 
or fat grafting, and those with implants in the prepectoral plane 
were excluded. We recorded patients’ age, body mass index 
(BMI), the presence of hypertension and diabetes mellitus, 
smoking history, breast ptosis grade, mastectomy type (nipple-
sparing mastectomy or total mastectomy), axillary operation 
status, neoadjuvant treatment, breast specimen weight, and re-
construction type (tissue expander or direct-to-implant). Two 
general surgeons performed the mastectomies, and the recon-
structions were performed by a single plastic surgeon. From 
March 2017 to January 2018, patients underwent surgery with a 
monopolar electrosurgical device (group 1) and from February 
2018 to September 2018, an ultrasonic dissection device was 
used (group 2). 
Surgical technique
After total mastectomy was performed by the breast surgeon, 
immediate breast reconstruction was performed by the plastic 
surgeon. First, we performed hemostasis in the whole surgical 
field using an ultrasonic dissection device (Harmonic; Ethicon, 
Cincinnati, OH, USA). The origin of the pectoralis major mus-
cle was dissected and elevated using the instrument (Fig. 1). Af-
ter the muscle was adequately elevated, we made a slit incision 
on a piece of acellular dermal matrix (ADM), which had been 
immersed in an antibiotic solution, and fixed the ADM in the 
new inframammary fold location using Vicryl 3-0 sutures. We 
then fixed the edges of the pectoralis major muscle with the 
ADM to create a pocket where the mammary implant or tissue 
expander would be inserted. A 400-mL Hemovac was inserted 
in the margin of the breast pocket. We copiously irrigated the 
breast pocket with a triple antibiotic solution (cefazolin, genta-
mycin, and metronidazole). After we applied amorphous beta-
dine on the breast skin, we changed into aseptic gloves and in-
serted the mammary implant (or tissue expander) into the 
breast pocket. Then, we closed the pocket by suturing the ADM 
and the pectoralis major muscle. After subcutaneous suturing, 
subdermal suturing was performed using the buried technique, 
and skin closure was performed using 5-0 nylon sutures. A mild 
compressive dressing was applied, and the operation was com-
pleted. Similar surgical techniques were used in the monopolar 
electrosurgical device group and the ultrasonic scalpel group; 
only the dissection device was different between the groups.
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Outcome variables
The outcome variables were duration of surgery (minutes), 
drain volume (mL), duration of drainage (days) and postopera-
tive complications (e.g., seroma, hematoma, flap necrosis, or 
surgical site infection). Seroma was defined as the presence of a 
fluid collection within 30 days of surgery beneath the skin flaps 
after drain removal, in sufficient quantity to cause the patient 
discomfort. Surgical site infections were assessed using the Cen-
ters for Disease Control and Prevention criteria, according to 
which an SSI is defined as an infection of the skin and subcuta-
neous tissue that occurs within 30 days postoperatively and sat-
isfies at least one of the following criteria: (1) purulent drainage 
from the superficial incision; (2) organisms (other than Staphy-
lococcus epidermidis) isolated from an aseptically obtained cul-
ture of fluid or tissue from the superficial incision; (3) at least 
one of the given signs or symptoms of infection (i.e., pain or 
tenderness; localized swelling; redness; heat; superficial incision 
deliberately opened by surgeon and was culture-positive or not 
cultured [a culture-negative finding does not meet this criteri-
on]); and (4) diagnosis of a superficial incisional surgical site in-
fection by the surgeon or attending physician. Hematoma was 
defined as the need to perform aspiration or surgical evacuation 
due to the collection of blood under the flap. Flap necrosis was 
defined as the need to perform surgical revision due to a flap 
wound that occurred after surgery.
Statistical analysis
Statistical analysis was conducted using SPSS version 23.0 (IBM 
Corp., Armonk, NY, USA). Baseline demographic characteris-
tics (Table 1), treatment information (Table 2), and outcomes 
(Tables 3, 4) were compared using the Student t-test, chi-square 
test, and Fisher exact test according to the intervention device. 
Univariate and multivariate analyses were performed using lo-
gistic regression to analyze the effects of the variables in each 
group. The multivariate analysis was performed using variables 
identified as affecting seroma development in the univariate 
analysis (intervention device, age, weight of specimen, BMI, and 
reconstruction type).
RESULTS
The monopolar electrosurgical device group (group 1) com-
prised 58 breasts, while the ultrasonic dissection device group 
Fig. 1. Device and intraoperative image of its use
(A) Harmonic Focus, ultrasonic 
shears, curved tip (Ethicon Endo-
Surgery, Inc., Cincinnati, OH, USA). 
(B, C) During the ultrasonic dissec-
tion to elevate the pectoralis major 
muscle, there was no muscle con-
traction, and hemostasis was 
straightforward. Furthermore, 




Variable Group 1 Group 2 P-value
Age (yr) 47.6±7.0 45.1±6.8 0.052
BMI (kg/m2) 23.3±2.8 22.4±2.8 0.089
Comorbidity
   DM 4 (6.3) 1 (1.7) 0.368
   HTN 1 (1.6) 1 (1.7) >0.999
   Smoking 1 (1.6) 3 (5.2) 0.345
Ptosis grade 0.401
   0 26 (40.6) 32 (55.2)
   1 24 (37.5) 17 (29.3)
   2 9 (14.1) 7 (12.1)
   3 5 (7.8) 2 (3.4)
Values are presented as mean±SD or number (%). 
Group 1, monopolar electrosurgical device group; group 2, ultrasonic dissection 
device group; BMI, body mass index; DM, diabetes mellitus; HTN, hypertension.
Table 1. Patient characteristics 
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(group 2) comprised 64 breasts. In a comparison of the baseline 
demographic characteristics of the two groups, we found that 
the patients in group 2 were older (group 1 vs. group 2: 47.6 ±  
7.0 years vs. 45.1 ± 6.8 years, P = 0.052), and that the average 
BMI was lower in group 1 (group 1 vs. group 2: 23.3 ± 2.8 kg/m2 
vs. 22.4 ± 2.8 kg/m2, P = 0.089). However, neither age nor BMI 
was statistically significant. Hypertension, diabetes mellitus, 
smoking, and ptosis grade were also similar between the groups 
(Table 1). In group 2, the specimen weight was significantly 
greater (group 1 vs. group 2: 460.9 ± 203.9 g vs. 356.3 ± 185.9 g, 
P = 0.004) We surveyed the types of mastectomy, axillary opera-
tion status, chemotherapy, and reconstruction type, and these 
variables were comparable (Table 2). Furthermore, the duration 
of surgery, drain volume, and duration of drainage were similar 
in both groups (Table 3). 
With respect to surgical outcomes, the seroma development 
rate was relatively high in group 1 (11 [17.2%] vs. 18 [31.0%], 
P = 0.090). Hematoma did not develop in any of the patients in 
group 2, but five cases of hematoma development were noted in 
group 1 (5 [8.6%] vs. 0 [0.0%], P = 0.022). The duration of sur-
gery, total drainage volume, duration of drainage, overall com-
plication rate, surgical site infection rate, and flap necrosis rate 
were comparable (Table 4).
Univariate analysis was performed to identify the factors af-
fecting the seroma development rate, and we found that the risk 
of seroma development was higher in group 1 than in group 2 
(odds ratio [OR] for electrocautery, 2.168; 95% CI, 0.922–
5.099; P = 0.076). Multivariate analysis was performed using 
variables that could clinically affect the occurrence of seroma. 
Age, BMI, specimen weight, reconstruction type, and interven-
tion type were included in the multivariable analysis; a signifi-
cantly lower risk of seroma development was observed in the ul-
trasonic dissection device group (OR for electrocautery, 3.252; 
95% CI, 1.242–8.516; P = 0.016) (Table 5). 
DISCUSSION 
We aimed to compare the effects of using an ultrasonic dissec-
tion device and a monopolar electrosurgical device on seroma 
formation and short-term outcomes in patients undergoing 
prosthetic breast reconstruction after mastectomy, and found 
that that the rate of seroma development was lower in the ultra-
Variable Group 1 Group 2 P-value
Duration of surgery (min) 102.7±24.4 98.2±31.7 0.439
Drain volume (mL) 1,677.7±639.0 1,762.7±532.1 0.484
Duration of drainage (day) 18.9±4.5 17.8±3.3 0.205
Values are presented as mean±SD.
Group 1, monopolar electrosurgical device group; group 2, ultrasonic dissection 
device group.
Table 3. Outcomes of surgery 
Variable Group 1 Group 2 P-value
Seroma 11 (17.2) 18 (31.0) 0.090
Hematoma 0 5 (8.6) 0.022
Surgical site infection 2 (3.1) 3 (5.2) 0.668
Flap necrosis 5 (7.8) 4 (6.9) 1.000
Overall complication rate 14 (26.5) 16 (39.1) 0.274
Values are presented as number (%).
Group 1, monopolar electrosurgical device group; group 2, ultrasonic dissection 
device group.
Table 4. Complications of surgery 
Adjusted OR (95% CI) P-value
Intervention 0.016
   Ultrasonic dissection  1 (reference)
   Electrocautery 3.252 (1.242–8.516)
Age 1.053 (0.986–1.125) 0.123
Weight of specimen 1.002 (0.999–1.005) 0.198
BMI 1.025 (0.831–1.265) 0.816
General surgeon 0.174
   A  1 (reference)
   B 0.497 (0.181–1.363)
Reconstruction type 0.143
   Direct-to-implant  1 (reference)
   Tissue expander 2.033 (0.787–5.252)
OR, odds ratio; CI, confidence interval; BMI, body mass index.
Table 5. Multivariate analysis of variables affecting the 
likelihood of seroma development
Variable Group 1 Group 2 P-value
Type of mastectomy 0.379
   Nipple-sparing mastectomy 27 (42.2) 30 (51.7)
   Skin-sparing mastectomy 14 (21.9) 14 (24.1)
   Total mastectomy 23 (35.9) 14 (24.1)
Axillary operation 0.679
   SLNB 49 (76.6) 42 (72.4)
   ALND 15 (23.6) 16 (27.6)
Neoadjuvant chemotherapy 17 (26.6) 12 (20.7) 0.525
Specimen weight (g) 460.9±203.9 356.3±185.9 0.004
General surgeon 0.425
   A 42 (65.6) 34 (58.6)
   B 22 (34.4) 24 (41.4)
Reconstruction type 0.229
   Tissue expander insertion 40 (62.5) 30 (51.7)
   Direct-to-implant 24 (37.5) 28 (48.3)
Values are presented as number (%) or mean±SD.
Group 1, monopolar electrosurgical device group; group 2, ultrasonic dissection 
device group; SLNB, sentinel lymph node biopsy; ALND, axillary lymph node 
dissection.
Table 2. Treatment information 
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sonic dissection device group (group 2). The incidence of 
short-term complications was lower in group 2, but this tenden-
cy was not statistically significant. There was no statistically sig-
nificant difference in the operative time between the two 
groups. The total drainage volume, duration of drainage, surgi-
cal site infection rate, and flap necrosis rate were also compara-
ble between the two groups. 
Ultrasonic dissection devices have been reported to be superi-
or to monopolar electrosurgical devices in many studies. They 
provide the advantages of better hemostasis with minimal ther-
mal damage, a reduced risk of nerve damage, the use of fewer in-
struments due to their combined vessel-sealing, tissue-cutting, 
and tissue-dissecting functionality, and less visual obstruction 
from smoke [13-16]. Using the principle of breaking hydrogen 
bonds due to the generation of ultrasonic energy, these devices 
dissect the tissue and seal the vessels and lymphatics. This 
method was first used in minimally invasive surgery, including 
laparoscopic surgery; since then, it has been gradually proven to 
be superior to traditional dissection techniques, as shown by a 
decreased incidence of postoperative complications, including a 
lower rate of seroma development. The superiority of ultrasonic 
dissection in breast surgery remains controversial, but a report 
has described good outcomes for a recently developed modified 
radical mastectomy technique using an ultrasonic dissection de-
vice compared to those reported for mastectomy performed us-
ing a monopolar electrosurgical device [10].
Despite being a retrospective study, this study was the first to 
compare the short-term complications of surgery using a mono-
polar electrocautery device and an ultrasonic dissection device 
in immediate implant-based breast reconstruction. Cases in 
which factors other than the tools used in the intervention could 
have affected surgical outcomes were excluded from this study. 
In addition, recommendations of ways to reduce the complica-
tion rate in prosthetic breast reconstruction, such as using ADM, 
irrigation of the breast pocket with antibiotic solution, and the 
surgeon wearing sterile gloves before insertion of the implant, 
were applied in the surgical procedures presented herein.
Seroma formation can be caused by many factors. Currently, 
the leading causes of seroma formation are thought to be persis-
tent inflammation after mastectomy, thermal damage to tissue, 
and lymphatic disruption. In this study, the use of an ultrasonic 
dissection device decreased the seroma formation rate. It seems 
that when elevating the pectoralis major muscle, there was less 
thermal damage of the anterior chest wall and muscle, which re-
duced the formation of seroma due to inflammation. In the he-
mostasis process, the ultrasonic scalpel is applied only to selec-
tive areas, unlike when a monopolar electrosurgical device is 
used; therefore, tissue damage is markedly reduced in the overall 
area of the surgical field.
In addition to a reduced incidence of seroma development, ul-
trasonic dissection devices have many other advantages. Char-
ring, which occurs when using a monopolar electrosurgical de-
vice for muscle elevation, is not produced with this device. 
Charring can be a risk factor for prosthesis-related infection be-
cause the charred substance is not entirely removed during the 
irrigation performed before inserting an implant. Therefore, di-
rect contact between the charred substance and the prosthesis is 
eliminated, thereby reducing the likelihood of infection. The 
need to administer a muscle relaxant is eliminated because ultra-
sonic dissection devices do not cause muscle contractions. They 
also reduce the possibility of anesthesia-related complications, 
such as anaphylaxis, and prevent an unnecessary prolongation 
of anesthesia time.
There are several limitations of this study. First, the sample size 
of the two groups was not sufficiently large, which may explain 
the presence of between-group differences in specimen weight 
and BMI. However, a sufficiently large sample size would be ex-
pected to eliminate such differences between the two groups. Of 
particular note, a statistically significant difference was noted for 
specimen weight (group 1 vs. group 2: 460.9 ± 203.9 g vs. 
356.3 ± 185.9 g, P = 0.004). However, higher-weight specimens 
are generally associated with increased seroma incidence and 
drainage volume. Therefore, the multivariate analysis adjusted 
for the possible effects of differences in specimen weight on the 
incidence of seroma in the monopolar electrosurgical group. Sec-
ond, the general surgeons did not use the ultrasonic dissection 
device in a way consistent with how the plastic surgeon did so. 
The surgical technique used in mastectomy is expected to have a 
significant effect on seroma formation after reconstruction.
In conclusion, the rate of seroma formation can be slightly re-
duced by using an ultrasonic dissection device for immediate 
implant-based breast reconstruction. However, further random-
ized controlled studies are required to verify our results and to 
assess the cost-effectiveness of this technique.
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